BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Net income

annual net income:

$426.86M+$259.21M(+154.62%)
December 31, 2024

Summary

  • As of today (September 9, 2025), BMRN annual net profit is $426.86 million, with the most recent change of +$259.21 million (+154.62%) on December 31, 2024.
  • During the last 3 years, BMRN annual net income has risen by +$490.94 million (+766.13%).
  • BMRN annual net income is now -50.31% below its all-time high of $859.10 million, reached on December 31, 2020.

Performance

BMRN Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

quarterly net income:

$240.53M+$54.85M(+29.54%)
June 30, 2025

Summary

  • As of today (September 9, 2025), BMRN quarterly net profit is $240.53 million, with the most recent change of +$54.85 million (+29.54%) on June 30, 2025.
  • Over the past year, BMRN quarterly net income has increased by +$133.36 million (+124.43%).
  • BMRN quarterly net income is now -69.35% below its all-time high of $784.80 million, reached on September 30, 2020.

Performance

BMRN quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM net income:

$657.24M+$133.36M(+25.46%)
June 30, 2025

Summary

  • As of today (September 9, 2025), BMRN TTM net profit is $657.24 million, with the most recent change of +$133.36 million (+25.46%) on June 30, 2025.
  • Over the past year, BMRN TTM net income has increased by +$400.65 million (+156.15%).
  • BMRN TTM net income is now -23.50% below its all-time high of $859.10 million, reached on December 31, 2020.

Performance

BMRN TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BMRN Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+154.6%+124.4%+156.2%
3 y3 years+766.1%+769.5%+1115.5%
5 y5 years+1889.9%+924.2%+437.6%

BMRN Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+766.1%at high+3715.9%at high+1115.5%
5 y5-year-50.3%+766.1%-69.3%+515.4%-23.5%+1125.7%
alltimeall time-50.3%+167.7%-69.3%+157.4%-23.5%+204.3%

BMRN Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$240.53M(+29.5%)
$657.24M(+25.5%)
Mar 2025
-
$185.69M(+48.6%)
$523.88M(+22.7%)
Dec 2024
$426.86M(+154.6%)
$124.94M(+17.8%)
$426.86M(+32.4%)
Sep 2024
-
$106.08M(-1.0%)
$322.29M(+25.6%)
Jun 2024
-
$107.17M(+20.9%)
$256.59M(+24.9%)
Mar 2024
-
$88.66M(+335.2%)
$205.46M(+22.6%)
Dec 2023
$167.65M(+18.4%)
$20.38M(-49.5%)
$167.65M(+14.0%)
Sep 2023
-
$40.38M(-27.9%)
$147.02M(+47.0%)
Jun 2023
-
$56.04M(+10.2%)
$99.99M(+39.6%)
Mar 2023
-
$50.85M(<-9900.0%)
$71.61M(-49.4%)
Dec 2022
$141.56M(-320.9%)
-$249.00K(-96.3%)
$141.56M(+68.7%)
Sep 2022
-
-$6.65M(-124.0%)
$83.91M(+55.2%)
Jun 2022
-
$27.66M(-77.1%)
$54.07M(+37.4%)
Mar 2022
-
$120.80M(-308.6%)
$39.35M(-161.4%)
Dec 2021
-$64.08M(-107.5%)
-$57.90M(+58.7%)
-$64.08M(-502.6%)
Sep 2021
-
-$36.49M(-382.0%)
$15.92M(-98.1%)
Jun 2021
-
$12.94M(-25.5%)
$837.21M(+5.3%)
Mar 2021
-
$17.37M(-21.4%)
$795.09M(-7.5%)
Dec 2020
$859.10M(-3702.4%)
$22.10M(-97.2%)
$859.10M(+0.8%)
Sep 2020
-
$784.80M(-2789.2%)
$852.02M(+596.9%)
Jun 2020
-
-$29.18M(-135.9%)
$122.26M(+7.2%)
Mar 2020
-
$81.38M(+441.7%)
$114.01M(-578.1%)
Dec 2019
-$23.85M(-69.1%)
$15.02M(-72.7%)
-$23.85M(-43.9%)
Sep 2019
-
$55.04M(-247.0%)
-$42.52M(-61.4%)
Jun 2019
-
-$37.44M(-33.7%)
-$110.18M(+23.1%)
Mar 2019
-
-$56.47M(+1447.2%)
-$89.53M(+16.0%)
Dec 2018
-$77.21M(-34.0%)
-$3.65M(-71.1%)
-$77.21M(-38.2%)
Sep 2018
-
-$12.62M(-24.8%)
-$124.95M(+0.1%)
Jun 2018
-
-$16.79M(-62.0%)
-$124.86M(-13.8%)
Mar 2018
-
-$44.15M(-14.1%)
-$144.90M(+23.8%)
Dec 2017
-$117.04M(-81.4%)
-$51.39M(+310.2%)
-$117.04M(-25.2%)
Sep 2017
-
-$12.53M(-66.0%)
-$156.37M(-13.7%)
Jun 2017
-
-$36.83M(+126.1%)
-$181.27M(-67.8%)
Mar 2017
-
-$16.29M(-82.0%)
-$563.45M(-10.6%)
Dec 2016
-$630.21M(+266.8%)
-$90.72M(+142.4%)
-$630.21M(+33.8%)
Sep 2016
-
-$37.42M(-91.1%)
-$470.87M(-10.2%)
Jun 2016
-
-$419.01M(+404.5%)
-$524.37M(+179.9%)
Mar 2016
-
-$83.05M(-221.0%)
-$187.35M(+9.1%)
Dec 2015
-$171.80M(+28.2%)
$68.62M(-175.5%)
-$171.80M(-44.6%)
Sep 2015
-
-$90.93M(+10.9%)
-$310.21M(+46.4%)
Jun 2015
-
-$81.99M(+21.5%)
-$211.84M(+29.7%)
Mar 2015
-
-$67.50M(-3.3%)
-$163.35M(+21.9%)
Dec 2014
-$133.97M(-24.0%)
-$69.80M(-1037.5%)
-$133.97M(+6.2%)
Sep 2014
-
$7.45M(-122.2%)
-$126.16M(-32.4%)
Jun 2014
-
-$33.50M(-12.1%)
-$186.63M(+6.9%)
Mar 2014
-
-$38.12M(-38.5%)
-$174.66M(-1.0%)
Dec 2013
-$176.35M(+54.2%)
-$61.99M(+16.9%)
-$176.35M(+5.4%)
Sep 2013
-
-$53.02M(+146.2%)
-$167.38M(+39.8%)
Jun 2013
-
-$21.53M(-45.9%)
-$119.71M(-8.0%)
Mar 2013
-
-$39.81M(-24.9%)
-$130.19M(+13.9%)
Dec 2012
-$114.35M(+112.4%)
-$53.01M(+889.6%)
-$114.35M(+29.8%)
Sep 2012
-
-$5.36M(-83.3%)
-$88.07M(-12.3%)
Jun 2012
-
-$32.01M(+33.5%)
-$100.37M(+36.7%)
Mar 2012
-
-$23.97M(-10.3%)
-$73.44M(+36.4%)
DateAnnualQuarterlyTTM
Dec 2011
-$53.84M(-126.2%)
-$26.73M(+51.4%)
-$53.84M(+37.0%)
Sep 2011
-
-$17.65M(+247.7%)
-$39.29M(-120.1%)
Jun 2011
-
-$5.08M(+16.2%)
$195.70M(-2.3%)
Mar 2011
-
-$4.37M(-64.1%)
$200.30M(-2.7%)
Dec 2010
$205.82M(<-9900.0%)
-$12.19M(-105.6%)
$205.82M(-7.6%)
Sep 2010
-
$217.33M(<-9900.0%)
$222.72M(+1752.1%)
Jun 2010
-
-$477.00K(-141.4%)
$12.03M(-13.0%)
Mar 2010
-
$1.15M(-75.6%)
$13.81M(-2924.9%)
Dec 2009
-$488.00K(-101.6%)
$4.71M(-29.1%)
-$489.00K(-102.5%)
Sep 2009
-
$6.64M(+406.1%)
$19.31M(+43.1%)
Jun 2009
-
$1.31M(-110.0%)
$13.49M(-15.6%)
Mar 2009
-
-$13.15M(-153.7%)
$15.99M(-48.1%)
Dec 2008
$30.83M(-295.1%)
$24.51M(+2856.1%)
$30.83M(+246.6%)
Sep 2008
-
$829.00K(-78.2%)
$8.90M(+212.0%)
Jun 2008
-
$3.81M(+126.0%)
$2.85M(-159.1%)
Mar 2008
-
$1.69M(-34.4%)
-$4.82M(-69.5%)
Dec 2007
-$15.80M(-44.6%)
$2.57M(-149.3%)
-$15.80M(-45.1%)
Sep 2007
-
-$5.22M(+35.0%)
-$28.76M(-6.0%)
Jun 2007
-
-$3.86M(-58.4%)
-$30.58M(+9.1%)
Mar 2007
-
-$9.29M(-10.6%)
-$28.05M(-1.7%)
Dec 2006
-$28.53M(-61.6%)
-$10.39M(+47.7%)
-$28.53M(-13.9%)
Sep 2006
-
-$7.04M(+431.0%)
-$33.14M(-20.3%)
Jun 2006
-
-$1.32M(-86.5%)
-$41.58M(-32.5%)
Mar 2006
-
-$9.78M(-34.8%)
-$61.59M(-17.1%)
Dec 2005
-$74.27M(-60.4%)
-$15.00M(-3.1%)
-$74.27M(-47.6%)
Sep 2005
-
-$15.48M(-27.5%)
-$141.70M(-9.0%)
Jun 2005
-
-$21.34M(-5.0%)
-$155.70M(-18.0%)
Mar 2005
-
-$22.46M(-72.8%)
-$189.96M(+1.3%)
Dec 2004
-$187.44M(+145.4%)
-$82.42M(+179.6%)
-$187.44M(+43.4%)
Sep 2004
-
-$29.48M(-47.0%)
-$130.75M(+6.7%)
Jun 2004
-
-$55.60M(+178.8%)
-$122.56M(+61.1%)
Mar 2004
-
-$19.95M(-22.5%)
-$76.06M(-0.4%)
Dec 2003
-$76.38M(-1.3%)
-$25.73M(+20.8%)
-$76.38M(+9.1%)
Sep 2003
-
-$21.29M(+134.0%)
-$69.97M(+6.7%)
Jun 2003
-
-$9.10M(-55.1%)
-$65.57M(-7.7%)
Mar 2003
-
-$20.26M(+4.8%)
-$71.05M(-8.2%)
Dec 2002
-$77.37M(+34.7%)
-$19.32M(+14.4%)
-$77.37M(-16.2%)
Sep 2002
-
-$16.89M(+15.9%)
-$92.33M(+6.8%)
Jun 2002
-
-$14.57M(-45.2%)
-$86.46M(+3.1%)
Mar 2002
-
-$26.58M(-22.5%)
-$83.85M(+25.2%)
Dec 2001
-$57.43M(+53.7%)
-$34.28M(+211.2%)
-$66.97M(+55.5%)
Sep 2001
-
-$11.02M(-8.0%)
-$43.08M(+7.1%)
Jun 2001
-
-$11.97M(+23.4%)
-$40.21M(+13.8%)
Mar 2001
-
-$9.70M(-6.7%)
-$35.33M(-5.4%)
Dec 2000
-$37.36M(+33.1%)
-$10.39M(+27.6%)
-$37.36M(+3.8%)
Sep 2000
-
-$8.15M(+15.0%)
-$36.01M(+1.4%)
Jun 2000
-
-$7.09M(-39.6%)
-$35.50M(+0.9%)
Mar 2000
-
-$11.74M(+29.9%)
-$35.20M(+25.4%)
Dec 1999
-$28.07M(+128.0%)
-$9.04M(+18.3%)
-$28.07M(+47.5%)
Sep 1999
-
-$7.64M(+12.7%)
-$19.03M(+67.1%)
Jun 1999
-
-$6.78M(+47.1%)
-$11.39M(+147.1%)
Mar 1999
-
-$4.61M
-$4.61M
Dec 1998
-$12.31M(+345.7%)
-
-
Dec 1997
-$2.76M
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual net profit?
  • What is the all time high annual net income for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual net income year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly net profit?
  • What is the all time high quarterly net income for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly net income year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM net profit?
  • What is the all time high TTM net income for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM net income year-on-year change?

What is BioMarin Pharmaceutical Inc. annual net profit?

The current annual net income of BMRN is $426.86M

What is the all time high annual net income for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual net profit is $859.10M

What is BioMarin Pharmaceutical Inc. annual net income year-on-year change?

Over the past year, BMRN annual net profit has changed by +$259.21M (+154.62%)

What is BioMarin Pharmaceutical Inc. quarterly net profit?

The current quarterly net income of BMRN is $240.53M

What is the all time high quarterly net income for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly net profit is $784.80M

What is BioMarin Pharmaceutical Inc. quarterly net income year-on-year change?

Over the past year, BMRN quarterly net profit has changed by +$133.36M (+124.43%)

What is BioMarin Pharmaceutical Inc. TTM net profit?

The current TTM net income of BMRN is $657.24M

What is the all time high TTM net income for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM net profit is $859.10M

What is BioMarin Pharmaceutical Inc. TTM net income year-on-year change?

Over the past year, BMRN TTM net profit has changed by +$400.65M (+156.15%)
On this page